Levosulpiride Injection

SOGPRIDE INJECTION 

Product Description

SOGPRIDE contains levosulpiride 12.5 mg/ml, providing 25 mg of active ingredient in each 2 ml ampoule. It is a gastrointestinal prokinetic formulation that helps improve the coordinated movement of the stomach and upper digestive tract. By supporting gastric motility and promoting more efficient movement of stomach contents, it can help manage digestive complaints associated with impaired gastric emptying. The 2 ml ampoule provides a measured strength for administration by a qualified healthcare professional.

Indication

• Gastroparesis and delayed gastric emptying
• Functional dyspepsia
• Bloating and post-meal fullness
• Nausea associated with reduced gastric motility
• Upper gastrointestinal motility disorders

Key Benefits

• Supports effective gastric emptying
• Promotes coordinated gastrointestinal movement
• Helps relieve bloating and abdominal fullness
• May reduce discomfort associated with delayed digestion
• Provides a measured injectable form of Levosulpiride for clinical use